Is the severity of an Adverse Event (AE) equivalent to its seriousness?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The correct answer is B. FALSE. The severity of an adverse event (AE) is not the same as its seriousness. These are distinct concepts in clinical research and Good Clinical Practice (GCP). Severity refers to the intensity or grade of the adverse event (mild, moderate, severe), which is a measure of how strong the symptoms are, as defined in the study 1.

  • Severity is categorized based on the level of interference with the subject's usual activities, ranging from mild (transient and easily tolerated) to severe (considerable interference and potentially incapacitating or life-threatening) 1.
  • Seriousness, on the other hand, is determined by the outcome or consequence of the event, such as whether it results in hospitalization, is life-threatening, causes death, results in persistent disability, or is a congenital anomaly. Key points to consider:
  • A severe adverse event is not necessarily serious by regulatory definition, as noted in the study 1.
  • The terms "severe" and "serious" are often confused but have distinct meanings in the context of adverse event reporting.
  • Understanding this distinction is crucial for proper adverse event reporting and patient safety monitoring in clinical trials, ultimately impacting morbidity, mortality, and quality of life.

From the Research

Adverse Event Severity and Seriousness

  • The severity of an adverse event (AE) and its seriousness are related but distinct concepts in the context of clinical trials and pharmacovigilance.
  • Severity refers to the intensity or extent of the adverse event, while seriousness refers to the potential of the event to cause significant harm or risk to the patient.
  • There is no direct evidence in the provided studies 2, 3, 4, 5, 6 to support the claim that the severity of an AE is the same as its seriousness.

Definition of Seriousness

  • A serious adverse event is typically defined as one that is life-threatening, requires hospitalization, or results in significant disability or death.
  • The provided studies do not directly address the definition of seriousness in the context of adverse events.

Conclusion Based on Provided Information

  • Based on the information provided, it appears that the severity and seriousness of an adverse event are not the same thing.
  • Therefore, the correct answer would be B. FALSE, as the severity of an adverse event is not equivalent to its seriousness 2, 3, 4, 5, 6.

Related Questions

What elements are required for a research misconduct finding in GCP (Good Clinical Practice) certification?
What is the required timeframe for reporting a Serious Adverse Event (SAE) to the local Institutional Review Board (IRB) after becoming aware of the event?
Which entities are subject to the Health Insurance Portability and Accountability Act (HIPAA) privacy rule: health plans, health care clearinghouses, or other?
Does authorization for Protected Health Information (PHI) disclosure exempt tracking of disclosures?
Must every aspect of a research study be documented in compliance with Good Clinical Practice (GCP) guidelines to obtain useful data?
What is the mechanism of action of Lokelma (sodium zirconium cyclosilicate)?
What action should be taken upon discovery of a participant's death in a clinical trial?
Can buprenorphine (Subutex) tests yield false positive results?
Which adverse event feature is not used to determine expedited reporting to the Food and Drug Administration (FDA) by the Sponsor: seriousness, expectedness, causal relationship, or severity?
In which situation is a Serious Adverse Event (SAE) not required to be reported to the National Institute on Drug Abuse (NIDA) or designee within 24 hours: A. The investigator considers the SAE unrelated to study intervention, B. The SAE is non-fatal and non-life-threatening, C. The SAE occurs in a behavioral study, D. The SAE occurs in a non-Investigational New Drug (IND) study, E. The SAE occurs in the post-treatment observation period, or F. None of the above?
What is the treatment for acute uncomplicated diverticulitis in the elderly?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.